Our Somatic Genomics platform unveils a new universe of genetic variation to create transformational medicines. Learn more at Quotient-Tx.com

Life Sciences

Quotient Therapeutics

Geoffrey von Maltzahn

Matthew Young

Tobias Tilly

Jacob Rubens

Andrew Bayliffe

Joanne Yarker

The Research & Development team at Quotient Therapeutics is dedicated to advancing the Somatic Genomics platform by exploring genetic variations to inform the creation of innovative therapeutic solutions. Comprising experts in engineering, bioinformatics, and genomic sciences, the team collaborates to design experiments, analyze data, and translate findings into novel medicines that address unmet medical needs. Their work combines cutting-edge technology with strategic insight to drive the development of transformational healthcare solutions.

Research & Development

The Leadership Team at Quotient Therapeutics drives the strategic vision and operational excellence of the company, overseeing the development and implementation of innovative therapies based on somatic genomics. Comprising key executives with expertise in drug discovery, scientific research, and operational management, this team collaborates to advance the company's mission of creating transformational medicines through cutting-edge genetic research.

Quotient Therapeutics

Org chart

Teams

Research & Development

Leadership Team

Offices

Quotient Therapeutics

Org chart

Teams

Research & Development

Leadership Team

Offices

Related companies